Dr. Nishi Bhopal, MD and sleep physician Dr. Audrey Wells, MD discuss why women’s sleep disorders are often missed and walk clinicians through three familiar midlife cases, emphasizing perimenopause/menopause as a window of escalating risk and atypical presentations.
In this interview, Heather Lill from Project Sleep explains the Project Sleep Helpline, a free national resource that helps people and clinicians navigate sleep health questions and sleep disorders by phone, email, or web form. Project Sleep is a 501(c)(3) nonprofit focused on sleep health, sleep equity, and sleep disorder awareness through programs, advocacy training, and resources. Heather describes how the helpline supports anyone at any stage of the diagnostic journey by providing evidence-based information, connecting callers to treatment options, sleep physicians, CBT-I and behavioral sleep medicine directories, patient organizations, support groups, and local resources—especially for those facing barriers to care such as being uninsured or underinsured. She explains follow-up and tracking through a CRM, scope boundaries (not providing medical advice).
Dr. Nishi Bhopal reviews dual orexin receptor antagonists (DORAs)—suvorexant, lemborexant, and daridorexant—explaining how they reduce wake drive by blocking OX1R/OX2R and how this differs from GABAergic hypnotics. She covers dosing timing, food effects, differing half-lives, CYP3A4 interactions, and key adverse effects including sleep paralysis, hypnagogic hallucinations, vivid dreams, next-day sleepiness, and complex sleep behaviors. She argues clinicians are often disappointed when DORAs are expected to fix non-target problems such as circadian disruption, sleep apnea, substance-related sleep fragmentation, or lifestyle-driven hyperarousal, emphasizing accurate insomnia diagnosis using circadian rhythm, sleep drive, and hyperarousal drivers. She highlights best-fit populations (older adults, COMISA, and substance use disorders), discusses longer-term safety data up to 12 months, recommends CBT-I and intermittent dosing to reduce conditioned sleep anxiety, and provides a practical monitoring protocol and medication-selection nuances.
Pop Quiz
❓True or False: Oral lavender (Silexan) 80 mg/day has demonstrated improvement in sleep quality as a secondary outcome in placebo-controlled RCTs of patients with anxiety disorders.
(Answer is below)*
Jamila is a 45-year-old woman with anxiety, depression, and difficulty both falling asleep and staying asleep.
Her primary care physician prescribed lorazepam (Ativan), but she wasn’t enthusiastic about taking a medication every night.
“Is there anything more natural I can try?” she asked.
It’s a question I hear regularly in clinical practice.
Patients are increasingly looking for alternatives to sedatives and sleep medications. At the same time, clinicians want interventions supported by evidence rather than anecdotes.
Lavender sits at the intersection of those two worlds.
Used for centuries in traditional systems of medicine and increasingly studied in modern clinical trials, lavender has emerged as one of the better-researched botanical interventions for anxiety and sleep.
But is lavender actually evidence-based? And if so, which patients are most likely to benefit?
The short answer is yes.
Lavender is one of the most extensively studied botanical interventions for anxiety and sleep.
While many supplements have little more than traditional use or preliminary data behind them, lavender has been evaluated in multiple randomized placebo-controlled trials and meta-analyses.
The strongest evidence exists for a standardized oral lavender oil preparation known as Silexan®.
Originally developed in Germany, Silexan has been studied in patients with generalized anxiety disorder, mixed anxiety and depression, subthreshold anxiety, and anxiety-related sleep disturbances.
Across these studies, patients experienced meaningful improvements in anxiety symptoms, sleep quality, and overall wellbeing compared to placebo.
This is important because many patients with insomnia aren’t struggling because they lack enough sedative medication.
They’re struggling because their nervous system remains activated long after their head hits the pillow.
In those patients, reducing anxiety may be more important than increasing sedation.
That’s where lavender appears to offer its greatest benefit.
One of the most interesting things about lavender is that it doesn’t behave like a traditional sleeping pill.
When patients hear that something helps with sleep, they often assume it works by causing drowsiness.
Lavender appears to work differently.
Its primary active compounds, linalool and linalyl acetate, influence several pathways involved in stress regulation and relaxation.
Research suggests lavender may modulate GABAergic signaling, support parasympathetic nervous system activity, and reduce physiological markers of stress and hyperarousal.
In practical terms, lavender seems to help patients feel calmer rather than sleepier.
This distinction becomes important when we look at the research on oral lavender.
In one analysis of Silexan studies, nearly all of the observed sleep benefit was explained by improvements in anxiety.
In other words, patients slept better because they felt less anxious, not because lavender was acting as a sedative.
From an integrative psychiatry perspective, this makes a lot of sense.
Many patients with insomnia don’t need a stronger sleep aid. They need help turning down the volume on a nervous system that has become stuck in a state of hypervigilance.
If you’re interested in practical discussions on insomnia, sleep supplements, integrative psychiatry, and behavioral sleep medicine, join our clinician newsletter for weekly insights and clinical pearls.
No.
This is one of the biggest misconceptions about lavender.
Unlike benzodiazepines, lavender does not appear to induce significant sedation, impair cognition, or produce next-day grogginess. It also lacks the dependence and withdrawal concerns associated with many conventional anxiolytics.
This doesn’t mean lavender is weak.
In fact, studies comparing oral lavender to conventional anxiety treatments have found improvements in anxiety symptoms comparable to low-dose lorazepam and paroxetine in certain patient populations.
The difference is in the mechanism.
Rather than forcing sleep, lavender appears to create conditions that are more favorable for sleep by reducing anxiety and physiological arousal.
For patients with anxiety and hyperarousal, this can be a significant advantage.
| Feature | Oral Lavender (Silexan®) | Lavender Aromatherapy |
|---|---|---|
| Evidence Base | Multiple randomized placebo-controlled trials | Multiple clinical trials and meta-analyses |
| Primary Outcome Studied | Anxiety symptoms and sleep quality | Sleep quality and relaxation |
| Typical Intervention | 80–160 mg daily | Inhalation via diffuser, pillow spray, or essential oil |
| Mechanism Supported by Research | Anxiety reduction appears to mediate sleep benefits | Anxiety reduction appears to mediate sleep benefits |
| Sleep Effects Observed | Improved PSQI scores and sleep quality | Improved subjective sleep quality and sleep onset |
| Sedation | Not observed in clinical trials | Not observed in clinical trials |
If anxiety is clearly driving the sleep complaint, I generally lean toward a standardized oral lavender preparation because the evidence is stronger and dosing is more consistent.
If a patient prefers a non-ingestible option, enjoys aromatherapy, or is looking for a simple addition to an existing sleep routine, inhaled lavender can be a reasonable starting point.
In some cases, I’ll even use both. A patient might take oral lavender during the day to help reduce anxiety while using a diffuser or pillow spray at night as part of a calming bedtime routine.
The key is matching the intervention to the patient rather than assuming every sleep problem requires the same solution.
Oral Silexan has the strongest clinical trial data. Most studies have used doses of 80–160 mg daily and demonstrate improvements in anxiety, sleep quality, and daytime functioning. Importantly, the sleep benefits appear to be largely secondary to anxiety reduction.
Aromatherapy has a broader and more heterogeneous evidence base. Multiple meta-analyses suggest inhaled lavender can improve subjective sleep quality, particularly in older adults and patients with chronic medical conditions.
One mistake I see clinicians make is recommending lavender (or supplements in general) to every patient with insomnia.
In practice, lavender tends to work best when anxiety, stress, hyperarousal, and sleep-related worry are major contributors to the sleep disturbance.
The classic candidate is the “wired and tired” patient.
They may feel exhausted all day, only to find their mind racing when they finally get into bed.
They replay conversations, worry about tomorrow’s responsibilities, and become increasingly frustrated by their inability to fall asleep.
For these patients, lavender often fits naturally into a broader treatment plan.
Research also suggests potential benefits in:
By contrast, lavender is unlikely to meaningfully improve insomnia caused by untreated obstructive sleep apnea, restless leg syndrome, circadian rhythm disorders, or chronic sleep restriction.
As with most sleep interventions, success depends less on the supplement itself and more on whether you’ve correctly identified the underlying driver(s) of the insomnia.
I often tell clinicians to avoid falling into what I call the “green pharmacy” trap.
In conventional medicine, we sometimes reach for a prescription when we don’t fully understand the problem.
In integrative medicine, it’s easy to make the same mistake with supplements.
Instead of asking why someone can’t sleep, we simply replace a medication with magnesium, melatonin, lavender, or another supplement.
Patients aren’t looking for a different pill.
They’re looking for someone who can help them understand what’s driving the problem in the first place.
Lavender works best as an adjunct to a comprehensive treatment plan, not as a replacement for one.
That plan may include CBT-I, circadian interventions, stress management, treatment of sleep apnea, medication optimization, lifestyle changes, or nutritional support.
Supplements can be valuable tools.
They’re just rarely the entire answer.
Let’s go back to Jamila.
When she asked whether there was a natural alternative to lorazepam, we discussed several options. Ultimately, we decided to try oral lavender.
Not because I thought lavender would “fix” her insomnia.
But because anxiety appeared to be one of the major factors perpetuating it.
Alongside lavender, we worked on reducing sleep-related anxiety, challenging unhelpful beliefs about sleep, and implementing some mild sleep compression to improve sleep efficiency.
Over time, her sleep improved.
Now, was lavender solely responsible? Almost certainly not.
That’s an important lesson for clinicians.
Patients often ask whether a particular supplement works.
In reality, most successful outcomes come from addressing multiple contributing factors simultaneously.
Lavender was one tool in a much larger treatment plan.
One thing I occasionally do in practice is recommend oral lavender during the daytime rather than exclusively at bedtime.
Because it isn’t sedating, some patients find it helpful for reducing daytime anxiety and hyperarousal.
There’s another potential advantage as well.
Many patients develop a subtle psychological dependence on bedtime supplements. They begin to believe:
“I can only sleep if I take this.”
By using lavender earlier in the day, we may support anxiety reduction while avoiding the ritualization that sometimes develops around nighttime sleep aids.
One of lavender’s biggest advantages is its safety profile.
Compared to many conventional sleep and anxiety medications, adverse effects tend to be mild and self-limiting.
The most commonly reported side effects include:
In fact, I once had a patient from France who actually enjoyed the lavender aftertaste and looked forward to the burps. So even side effects are subjective.
This question comes up frequently.
Several years ago, case reports raised concerns about lavender’s potential estrogenic and antiandrogenic activity after reports of gynecomastia and premature breast development in children exposed to lavender-containing products.
Since then, the evidence has become more nuanced.
Adult clinical trials have not demonstrated meaningful estrogenic or androgenic effects at therapeutic doses.
Current evidence doesn’t suggest a clinically significant hormonal risk in adults using lavender appropriately.
That said, I still recommend caution and clinical judgment.
For pediatric patients, I generally avoid making strong recommendations given the lingering uncertainty.
For patients with hormone-sensitive cancers, I typically coordinate with their oncology team before recommending long-term lavender use. While available evidence has not identified a clear risk signal, the long-term data remains limited.
As with many areas of integrative medicine, the answer isn’t simply “safe” or “unsafe.”
It’s about weighing the available evidence in the context of the individual patient.
One challenge with supplement research is that the products studied in clinical trials are often very different from what patients purchase online.
When a study demonstrates efficacy for lavender, it’s usually evaluating a standardized preparation with known concentrations of active compounds.
That doesn’t necessarily mean every lavender product on the market will produce the same results.
This is why I encourage clinicians to develop a small list of trusted brands that emphasize quality control, third-party testing, and standardized manufacturing processes.
For oral lavender, one product I frequently recommend is Lavela®, which contains the same standardized lavender oil preparation studied in many of the Silexan trials.
The goal isn’t to create an exhaustive supplement catalog.
The goal is to identify a few high-quality options you can recommend confidently.
If you’d like a streamlined way to organize your preferred supplement recommendations and create a professional supplement dispensary for patients, you can create a free Fullscript practitioner account here.
Lavender may improve sleep quality, particularly when insomnia is associated with anxiety, stress, or hyperarousal. However, it’s best viewed as an adjunctive intervention rather than a primary treatment for chronic insomnia.
Yes. Lavender is one of the best-studied botanical interventions for anxiety and sleep. Multiple randomized placebo-controlled trials and meta-analyses support its use, particularly in anxiety-related sleep disturbances.
No. Lavender does not appear to improve sleep through sedation. Instead, it primarily works by reducing anxiety and supporting relaxation.
For oral lavender preparations such as Silexan®, most studies evaluated daily use over 6 to 10 weeks. Some patients notice benefits sooner, but improvements are generally not immediate.
Not necessarily.
Oral lavender has stronger clinical trial evidence and standardized dosing. Aromatherapy may offer more direct effects on relaxation and sleep quality. The best choice depends on patient preference, goals, and clinical context.
No.
Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the first-line treatment for chronic insomnia.
Lavender may complement CBT-I, but it should not replace it.
Patients with anxiety-related insomnia, stress-related sleep disruption, sleep-related worry, and hyperarousal tend to be the best candidates.
So, is lavender evidence-based?
Yes.
Among the many supplements marketed for sleep, lavender has one of the stronger evidence bases, particularly for anxiety-related insomnia and sleep disturbances associated with stress and hyperarousal.
What makes lavender particularly interesting is that it doesn’t work like a traditional sleeping pill.
Rather than forcing sleep through sedation, it appears to create conditions that are more favorable for sleep by calming the nervous system and reducing anxiety.
For the right patient, that distinction matters.
At the same time, it’s important not to overstate what lavender can do.
A patient with untreated sleep apnea, restless legs syndrome, circadian misalignment, or chronic sleep restriction is unlikely to experience meaningful improvement from lavender alone.
This is where an integrative sleep medicine approach becomes valuable.
Instead of asking, “Which supplement should I use?”
We start by asking:
“Why isn’t this patient sleeping?”
Once you identify the underlying drivers, you can build a treatment plan that may include behavioral interventions, circadian strategies, lifestyle changes, psychotherapy, medication optimization, sleep disorder evaluation, and occasionally, carefully selected supplements such as lavender.
The supplement is rarely the whole answer.
But sometimes it can be a useful piece of the puzzle.
Lavender is just one tool in the insomnia toolbox.
Inside the Clinical Sleep Kit (CSK), we teach clinicians how to evaluate insomnia systematically, identify underlying drivers, and build comprehensive treatment plans that go beyond medications and supplements.
If you’re interested in refining your approach to insomnia, sleep supplements, CBT-I, circadian medicine, and integrative sleep care, join the Clinical Sleep Kit waitlist to learn about upcoming training opportunities.
*Answer to the pop quiz: True. Multiple placebo-controlled RCTs have shown that Silexan significantly improves sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI), in patients with generalized anxiety disorder and mixed anxiety. In a pooled analysis, Silexan 80 mg/day reduced PSQI scores by approximately 3 points more than placebo, a clinically meaningful difference. Notably, this sleep benefit occurs without sedation or disruption of sleep architecture.
Did you learn something today? Click here to find out how Learner+ can help you meet your evolving educational goals.
References:
1. Dold M, et al. Efficacy of Silexan in patients with anxiety disorders: A meta-analysis of randomized, placebo-controlled trials. Eur Arch Psychiatry Clin Neurosci. 2023;273(7):1615-1628.
2. Kasper S, et al. Lavender oil preparation Silexan is effective in generalized anxiety disorder: A randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol. 2014;17(6):859-869.
3. Kasper S, Eckert A. Silexan in anxiety, depression, and related disorders: Pharmacological background and clinical data. Eur Arch Psychiatry Clin Neurosci. 2025;275(6):1621-1635.
4. Woelk H, Schläfke S. A multicenter, double-blind, randomized study of the lavender oil preparation Silexan in comparison to lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17(2):94-99.
Disclaimer: This information is for educational purposes only and is not intended to replace individualized medical advice, diagnosis, or treatment.
Get high yield sleep medicine tips, strategies, and clinical pearls delivered straight to your email inbox. Every email is also eligible for CMEs. Sign up for “SleepStudy”, my weekly newsletter.
Doctors only get an average of 2 hours of sleep medicine education. Grab this free course to learn what they didn’t teach you in residency…so that you can know exactly what to do to help your patients with sleep disorders (and get free CME).
Recent Comments